The loss of p21 facilitates AML1-ETO-induced leukemogenesis [4] and increases the proliferation of Bcr-Abl-transformed hematopoietic cells [46], suggesting that these oncogenes also contain signaling components that negatively modulate the proliferation of leukemia cells. This evidence concerns the gene RUNX1 and leukemia.